Literature DB >> 31564065

The relationship of volume overload and its control to hypertension in hemodialysis patients.

Jennifer E Flythe1,2, Nisha Bansal3,4.   

Abstract

Hypertension is highly prevalent and associated with poor clinical outcomes among individuals receiving maintenance hemodialysis (HD). Volume overload is a key modifiable contributor to hypertension and cardiovascular disease in the HD population. Despite their importance, assessment and treatment of volume overload and hypertension remain major clinical challenges and have substantial implications for both clinical outcomes and patient experiences of care. This review will summarize current data on the diagnosis, epidemiology, pathophysiology, and clinical consequences of hypertension and volume overload in HD patients. We will also identify priorities for future research studies.
© 2019 Wiley Periodicals, Inc.

Entities:  

Year:  2019        PMID: 31564065      PMCID: PMC6848760          DOI: 10.1111/sdi.12838

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  78 in total

Review 1.  Dialysate Sodium: Rationale for Evolution over Time.

Authors:  Jennifer E Flythe; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

2.  The rational clinical examination. Is this patient hypovolemic?

Authors:  S McGee; W B Abernethy; D L Simel
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

3.  Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).

Authors:  Jennifer L Bragg-Gresham; Rachel B Fissell; Nancy A Mason; George R Bailie; Brenda W Gillespie; Volker Wizemann; Jose Miguel Cruz; Takashi Akiba; Kiyoshi Kurokawa; Sylvia Ramirez; Eric W Young
Journal:  Am J Kidney Dis       Date:  2007-03       Impact factor: 8.860

4.  Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).

Authors:  Helen J Jefferies; Bhupinder Virk; Brigitte Schiller; John Moran; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-19       Impact factor: 8.237

5.  Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients.

Authors:  Magdalene M Assimon; Julia B Wenger; Lily Wang; Jennifer E Flythe
Journal:  Am J Kidney Dis       Date:  2016-08-26       Impact factor: 8.860

6.  Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Paul Muntner; Amanda Anderson; Jeanne Charleston; Zhen Chen; Virginia Ford; Gail Makos; Andrew O'Connor; Kalyani Perumal; Mahboob Rahman; Susan Steigerwalt; Valerie Teal; Raymond Townsend; Matthew Weir; Jackson T Wright
Journal:  Am J Kidney Dis       Date:  2009-12-05       Impact factor: 8.860

7.  Dialysate sodium prescription and blood pressure in hemodialysis patients.

Authors:  Manfred Hecking; Angelo Karaboyas; Hugh Rayner; Rajiv Saran; Ananda Sen; Masaaki Inaba; Jürgen Bommer; Walter H Hörl; Ronald L Pisoni; Bruce M Robinson; Gere Sunder-Plassmann; Friedrich K Port
Journal:  Am J Hypertens       Date:  2014-03-20       Impact factor: 2.689

8.  Hemodialysis-induced cardiac injury: determinants and associated outcomes.

Authors:  James O Burton; Helen J Jefferies; Nicholas M Selby; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 8.237

9.  Volume-associated ambulatory blood pressure patterns in hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2009-06-15       Impact factor: 10.190

10.  Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months.

Authors:  Wendy L St Peter; Stephen M Sozio; Tariq Shafi; Patti L Ephraim; Jason Luly; Aidan McDermott; Karen Bandeen-Roche; Klemens B Meyer; Deidra C Crews; Julia J Scialla; Dana C Miskulin; Navdeep Tangri; Bernard G Jaar; Wieneke M Michels; Albert W Wu; L Ebony Boulware
Journal:  BMC Nephrol       Date:  2013-11-12       Impact factor: 2.388

View more
  3 in total

1.  Integrating Monitoring of Volume Status and Blood Volume-Controlled Ultrafiltration into Extracorporeal Kidney Replacement Therapy.

Authors:  Sebastian Zschätzsch; Manuela Stauss-Grabo; Adelheid Gauly; Jennifer Braun
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-08-30

2.  Prediction of Heart Function and Volume Status in End-Stage Kidney Disease Patients through N-Terminal Pro-Brain Natriuretic Peptide.

Authors:  Kyung Ho Lee; Inki Moon; Young Seung Oh; Byung Chul Yu; Moo Yong Park; Jin Kuk Kim; Soo Jeong Choi
Journal:  Medicina (Kaunas)       Date:  2022-07-22       Impact factor: 2.948

3.  Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial.

Authors:  Fabio Solis-Jimenez; Lucia Monserrat Perez-Navarro; Ricardo Cabrera-Barron; Jesus Antonio Chida-Romero; Geovana Martin-Alemañy; Edgar Dehesa-López; Magdalena Madero; Rafael Valdez-Ortiz
Journal:  BMC Nephrol       Date:  2022-09-20       Impact factor: 2.585

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.